Topline Results: 18 Months of BAN2401 Might Work
The biotech company BioArctic Neuroscience announced positive topline results at the 18-month mark of a Phase 2b trial of BAN2401.
The biotech company BioArctic Neuroscience announced positive topline results at the 18-month mark of a Phase 2b trial of BAN2401.
Disclosing your health condition consists of two parts of a conversation: the disclosure itself and the request for support.
Could Join Dementia Research help recruit to your study? Meeting those essential targets
Three guest blogs from Early Career Researchers, on their visit as an observer at the recent ARUK Grant Review Board
CoLAB brings clinical research teams and external partners — including patients, study coordinators, nurses, and physicians — face-to-face for a dress rehearsal of a clinical trial protocol.
Aβ-PET scans may be the norm for AD research studies, but their use is limited. According to a study published June 11 in JAMA Neurology, the time may have come to expand access to the scans.
Are job prospects for PhD candidates and postdoctoral scientists dismal?
Interested in what digital technologies can do for dementia?
There’s a difference between mentoring and doling out to-do lists…
New report shows impact of Alzheimer’s Society work in Patient & Public Engagement, and highlights what help is on offer.
Using patient and public involvement to improve the research design and funding application for a project aimed at fostering a more collaborative approach to the NHS health check: the CaVIAR project (better Care Via Improved Access to Records)
There has been an increased emphasis on involving patients and the public in research. While this sounds like a positive movement, are guideline developers actually involving patients?
Get all the support you need sent straight to your inbox. Research news, oppertunities, blogs, podcasts, jobs, events, funding calls and much more – every friday!